BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25341045)

  • 1. HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation.
    Huang Y; Chen J; Lu C; Han J; Wang G; Song C; Zhu S; Wang C; Li G; Kang J; Wang J
    Cell Death Dis; 2014 Oct; 5(10):e1491. PubMed ID: 25341045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.
    Morris VA; Cummings CL; Korb B; Boaglio S; Oehler VG
    Mol Cell Biol; 2016 Feb; 36(4):559-73. PubMed ID: 26644403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4.
    Kee HJ; Kwon JS; Shin S; Ahn Y; Jeong MH; Kook H
    Vascul Pharmacol; 2011; 55(5-6):127-34. PubMed ID: 21763782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression.
    Kanai M; Wei D; Li Q; Jia Z; Ajani J; Le X; Yao J; Xie K
    Clin Cancer Res; 2006 Nov; 12(21):6395-402. PubMed ID: 17085651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells].
    Xia J; Chen D; Zuo G; Wei Q; You Z; Li D; Liu Z; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1062-6. PubMed ID: 25270209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA10 promotion of HDAC1 underpins the development of lung adenocarcinoma through the DNMT1-KLF4 axis.
    Ma T; Yan B; Hu Y; Zhang Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):71. PubMed ID: 33596966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
    Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
    Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1.
    Lee JW; Kim HS; Kim S; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Park KM; Ryoo ZY; Lee S
    Biochem Biophys Res Commun; 2012 Mar; 420(1):91-5. PubMed ID: 22405764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells.
    Wei D; Kanai M; Jia Z; Le X; Xie K
    Cancer Res; 2008 Jun; 68(12):4631-9. PubMed ID: 18559508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy.
    Kee HJ; Kook H
    J Mol Cell Cardiol; 2009 Dec; 47(6):770-80. PubMed ID: 19729022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krüppel-like factor 4 functions as a tumor suppressor in cervical carcinoma.
    Yang WT; Zheng PS
    Cancer; 2012 Aug; 118(15):3691-702. PubMed ID: 22170594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia.
    Lai QY; He YZ; Peng XW; Zhou X; Liang D; Wang L
    Cell Commun Signal; 2019 Jul; 17(1):86. PubMed ID: 31358016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.
    Zupkovitz G; Grausenburger R; Brunmeir R; Senese S; Tischler J; Jurkin J; Rembold M; Meunier D; Egger G; Lagger S; Chiocca S; Propst F; Weitzer G; Seiser C
    Mol Cell Biol; 2010 Mar; 30(5):1171-81. PubMed ID: 20028735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.
    Tickenbrock L; Klein HU; Trento C; Hascher A; Göllner S; Bäumer N; Kuss R; Agrawal S; Bug G; Serve H; Thiede C; Ehninger G; Stadt UZ; McClelland M; Wang Y; Becker A; Koschmieder S; Berdel WE; Dugas M; Müller-Tidow C;
    Leuk Res; 2011 May; 35(5):620-5. PubMed ID: 21176959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.
    Lagger G; O'Carroll D; Rembold M; Khier H; Tischler J; Weitzer G; Schuettengruber B; Hauser C; Brunmeir R; Jenuwein T; Seiser C
    EMBO J; 2002 Jun; 21(11):2672-81. PubMed ID: 12032080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.